TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Performance in critical tasks
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Functional Ankle Instability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of women screened for HIV risk
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Proportion of women who uptake PrEP for HIV prevention
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: knee pain change
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: change of effusion-synovitis volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Progression Free Survival (PFS-6)
Endpoint domain: Mortality/survival
Primary endpoint: Psoriasis area severity index (PASI) improvement from start of one drug to withdrawal of other drug
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Discomfort of daily breathlessness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Breathlessness interference of daily activities
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Rate of KT evaluation completion
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Trail Making Test (B-A score)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Number of hip-fractures
Endpoint domain: Mortality/survival
Primary endpoint: Pain With Movement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction or elimination of penetration and/or aspiration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in knee extensors maximal isometric torque output
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Completed bowel motion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Safety of a booster dose of COVID-19 vaccine
Endpoint domain: Adverse events/effects
Primary endpoint: Reactogenicity of a booster dose of COVID-19 vaccine
Endpoint domain: Adverse events/effects
Primary endpoint: Level of mobilisation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of Life by Myelodysplasia Scale (QUALMS) score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Adverse events at one year
Endpoint domain: Adverse events/effects
Primary endpoint: Adverse events at five years
Endpoint domain: Adverse events/effects
Primary endpoint: Change in C-peptide Area under the curve
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Percentage of patients willing to be randomised
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Healthy Eating Index (HEI)-2015 score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Knowledge of lower extremity self-care
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Gene expression of brush border enzymes and protein-related transporters
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Patients' assessment of personal quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Patients' experiences at the encounter
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Parenting Sense of Competence
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Prevalence of craving to the next biologic administration
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Character of craving to the next biologic administration
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Concentration of circulating autotaxin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vaccination status (COVID-19)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of intravitreal injections of Faricimab (6.0 mg)
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Feasibility of recruiting and retaining
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Prevention of premature labour
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Change-from-baseline in mean Hamilton Depression Rating Scale (HDRS-17) score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change-from-baseline in mean Beck Depression Inventory (BDI-II) scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: TPOAB levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: analytical performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intervention-related outcome rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the time curve of pain intensity during exercise (or cough)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient's and caregiver's treatment satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Patient's functioning & quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Morphine equivalent daily dose (MEDD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Participants Achieving Clinical Remission as per Partial Adapted Mayo Subscores for Ulcerative Colitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Percentage of Participants Achieving Clinical Remission as per Patient Reported Outcome (PRO2) for Crohn's Disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Area Under the Plasma Concentration-time Curve (AUC) for Caffeine, Omeprazole and Midazolam
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC From Time Zero to the Time t (AUC(0-last)) for S-warfarin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum Plasma Concentration (Cmax) for All Cocktail Substrates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Levels of cognitive functioning
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Ketones
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Facial Anxiety Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Temperature from vital signs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Behavioral Pain Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Work Productivity & Activity Impairment
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Disabilities of the Arm, Shoulder and Hand
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Percentage of Time with Tremor Present
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tremor Amplitude
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Knowledge Level
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in muscle soreness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Radiation Absorbed Doses in internal organs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in VSs and ECGs
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in SNOTT22 score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in Preparedness for caregiving
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Change in peak systolic velocity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in end diastolic velocity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in cavernous artery diameter
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Measure the area of the lesion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Response Rate (ORR) Based on RECIST 1.1 Criteria
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Neuroventilatory efficiency (NVE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Total Natriuresis After 24 Hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: First Occurrence of All-cause Mortality or Heart Failure Rehospitalization After 180 Days
Endpoint domain: Mortality/survival
Primary endpoint: Efficacy of cauterization techniques
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Proportion of Fabry disease
Endpoint domain: Mortality/survival
Primary endpoint: Finger tap reaction time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Proportion of excellent prognosis (mRS 0-1)
Endpoint domain: Mortality/survival
Primary endpoint: Postoperative changes in walking acceleration signals
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall frequency of serious adverse events (SAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Adjustment difficulties (BASE-6)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Annualized rate of severe asthma exacerbation events
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change in Obesity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: mean monocular, photopic best corrected distance visual acuity (BCDVA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Composite incidence of superficial and deep surgical site infections
Endpoint domain: Adverse events/effects
Primary endpoint: Change in tension over time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Urinary Tract Infection
Endpoint domain: Adverse events/effects
Primary endpoint: Bacterial Meningitis
Endpoint domain: Adverse events/effects
Primary endpoint: Bacteriaemia
Endpoint domain: Adverse events/effects
Primary endpoint: Mean placental perfusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean R2* relaxation rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Perception of the experience of healthy volunteers as patients
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Perception of healthcare team members of the use of repositioning sheets and the AMMP
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Perception of healthcare team members of the use of a novel process for patient handling
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: pain score with FLACC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the curve (last)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: complete remission rate of type 2 diabetes mellitus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Effective dose in preventing postspinal anesthesia hypotension
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Masseters Activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: ECCA scale score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: total amount of MME utilized
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to a documented new arrhythmia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Ankle functionality perceived by the patient
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Days of incapacity for work
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Sensitivity and Specificity of EyeCheckup to detect more than mild diabetic retinopathy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: Sensitivity and Specificity of EyeCheckup to detect vision-threatening diabetic retinopathy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: Change in serum osteocalcin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in serum PINP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Rate of change in movement time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Quadrants on Culture Plate of Cutibacterium Growth After ChloraPrep Application with Dermal Pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Number of Quadrants on Culture Plate of Cutibacterium Growth After ChloraPrep Application with Subdermal Pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Device or Procedure Related Serious Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Reduction in BPH Symptoms compared to Sham
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total amount of intraoperative fentanyl
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median cf/ctDNA concentration at pre- and post-radiation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median change in ct/ctDNA concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median levels of cfDNA collected longitudinally after completion of radiation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of cases with stopped nosebleeds
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Senescent cell abundance in blood (p16INK4A)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Change in occurrence of thromboembolic events
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in occurrence of arterial thrombotic events
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in occurrence of obstetric complications
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Immediate patency rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Incidence of post-thrombotic syndrome
Endpoint domain: Adverse events/effects
Primary endpoint: changes in the ratio of PaO2 to FiO2 from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Adherence to psychosocial treatment
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Physical Activity and Nutrition
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: BOLD fMRI parameter estimates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Proportion of women successfully operated
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Reports of serious adverse events (SAEs) throughout the active surveillance period
Endpoint domain: Adverse events/effects
Primary endpoint: Magnitude and breadth of HIV-specific binding antibody responses as assessed by multiplex assay
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: HIV-specific CD4+ and CD8+ T-cell response rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Incidence of acute kidney injury after surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Pain interference
Endpoint domain: Life impact
Endpoint subdomain: Pain
Primary endpoint: Adverse reaction of Cannabis
Endpoint domain: Adverse events/effects
Primary endpoint: Cannabis Use Disorder Identification Test
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Organ-specific uptake of 124I-AT-01
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Microenvironment-related indicators of tumor inflammation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Egg Reduction Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Sensory disintegration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinician Submental Fat Scale (CSFS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient Submental Fat Scale (PSFS)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Adherence to one of the two apps
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Credibility and Expectancy Questionnaire (CEQ)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Percentage of patients attaining 30% improvement of eye dryness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sound Quality
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum kisspeptin levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Change in PET tracer uptake in VOC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Association of PET tracer uptake with intensity of pain in VOC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Association of PET tracer uptake with clinical VOC markers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rates of failure of midlines
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bleeding during Percutaneous Dilational Tracheostomy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Dominant gp42-IgG epitopes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Balancing skills
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of postoperative pulmonary complications
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Rate of efficiency of Rectal and Intravenous Paracetamol
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Curve (AUC) Pain Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy (F1-scores)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of the frequency of intraoperative hypotension
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change of the absolute duration of intraoperative hypotension
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change of the relative duration of intraoperative hypotension
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Longitudinal change in cell types and cytokines
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: relative abundance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: inter-individual variation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: BI-RADS grade changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Cervical ligament length
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: RAD51-foci score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Total physiotherapy completion rate during hospitalization
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: 3rd next available appointment
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Percent of relational continuity
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of participants with infants that are preterm
Endpoint domain: Mortality/survival
Primary endpoint: Number of participants with infants with low birthweight
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Number of participants with a caesarean delivery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Positive Percent Agreement - Sensitivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Negative Percent Agreement - Specificity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in verbal rating scale (VRS)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in Motor score scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes